Kozak & Associates’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-112
Closed -$1.74K – 408
2023
Q4
$1.93K Hold
112
– – ﹤0.01% 319
2023
Q3
$1.57K Hold
112
– – ﹤0.01% 344
2023
Q2
$2.35K Hold
112
– – ﹤0.01% 301
2023
Q1
$3.15K Hold
112
– – ﹤0.01% 286
2022
Q4
$3K Hold
112
– – ﹤0.01% 287
2022
Q3
$3K Hold
112
– – ﹤0.01% 281
2022
Q2
$3K Buy
+112
New +$3.23K ﹤0.01% 319

Other funds holding EMBC

Kozak & Associates's EMBC Position: Q1 2024 in Review

Kozak & Associates sold out of Embecta (EMBC) in Q1 2024, closing a stake of 112 shares — an estimated $1.74K sold.

Kozak & Associates first reported a position in EMBC in Q2 2022 and held it in 7 quarters. The position peaked at $3.15K in Q1 2023. 372 funds tracked by Wall St. Rank hold EMBC as of Q1 2024.

  • Kozak & Associates reported no remaining Embecta position as of Q1 2024 after selling out during the quarter.
  • Kozak & Associates sold 112 Embecta shares in Q1 2024, an estimated $1.74K.
  • Kozak & Associates first reported a position in Embecta in Q2 2022 and held it in 7 quarters.
  • Kozak & Associates's Embecta position peaked at $3.15K in Q1 2023.
  • 372 funds tracked by Wall St. Rank held Embecta as of Q1 2024.

Based on Kozak & Associates's 13F filing for Q1 2024, filed 17 May 2024.